Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naphazoline/Pheniramine/Panthenol vs Naphazoline for Nasal Congestion
NCT01533220Phase 3Completed
- Sponsor
- EMS
- Start
- Jan 2013
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of naphazoline, pheniramine and panthenol in nasal congestion, common cold, respiratory allergy and 1 more (2 arms), sponsored by EMS. Primary endpoint: Peak Flow Nasal Inspiratory at 3 days. Started Jan 2013; status: completed.
02
Drugs
naphazolinepheniraminepanthenol
03
Conditions
nasal congestioncommon coldrespiratory allergyinfluenza
Beyond the preview
Go deeper on NCT01533220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533220.